Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Entourage Health Corp V.ENTG

Alternate Symbol(s):  ETRGF

Entourage Health Corp. is a Canada-based license holder producing and distributing cannabis products for both the medical and adult-use markets. The Company owns and operates a 26,000 square feet indoor facility in Aylmer, Ontario (the Aylmer Facility), specializing in product development and fulfillment for both adult-use and medical cannabis. The Company is focused on building a portfolio of... see more

TSXV:ENTG - Post Discussion

Entourage Health Corp > Annual Revenue Up a Hefty 54% to 54.8 Million=2+% of Market
View:
Post by Wrywisdom on Feb 14, 2022 5:43pm

Annual Revenue Up a Hefty 54% to 54.8 Million=2+% of Market

More than 2% of Canada's total market! This in comparison to most competitors experiencing revenue losses or struggling to maintain stasis:

           https://stockhouse.com/news/press-releases/2022/02/11/entourage-health-announces-preliminary-fiscal-year-2021-record-revenue-of-54-8

           The above annual revenue figure is approximately 2x the ridiculously low current valuation based on a fear based and manipulated stock price.

           We will be approaching .30 very soon.
Comment by Ebankbank on Feb 17, 2022 8:14am
I agree with your post, also like I said before with all the forks in the fire and direct to insured patient this should be way north of that number.  
Comment by prested on Feb 25, 2022 4:58pm
I'd say they had "fork" all in the fire except more bad news.
Comment by Wrywisdom on Feb 25, 2022 5:41pm
Exactly. We should be and will be way north of this number with a little patience. I am posting the comprehensive annual 2022 newsletter for those not familiaer with the host of ENTG accomplishments:                 https://stockhouse.com/news/press-releases/2022/01/06/entourage-health-posts-new-year-2022-shareholder-newsletter A truly incredible ...more  
Comment by shenry24 on Feb 27, 2022 5:49pm
But can we talk about the millions upon millions of debt payables coming due in the next few months, and how've they've yet to produce a positive cash flow and net income?  Can we also talk about the potential outcomes should these debts be called and what happens if Entourage can't satisfy them?  There's a reason no one is buying, no? 
Comment by Wrywisdom on Feb 28, 2022 1:45pm
Of course. I must assume that you missed this essential detailed release including highlighting the extension of 39 million dollars of debt financing in concert with the bank of Montreal until the end of 2022:              https://stockhouse.com/news/press-releases/2021/12/24/entourage-health-and-liuna-pension-fund-upsize-credit-facility-with-additional    ...more  
Comment by shenry24 on Feb 28, 2022 2:59pm
It is, somewhat comforting, knowing we'll get to see another financial statement, or two, before....  before, I don't know what exactly, but the end of 2022 is only 10 months away.  Entourage owes LIUNA more money than they make, and, if I'm not mistaken, correct me if I'm wrong, they are also majority stockholders.  Which puts, the fate of the company, in someone ...more  
Comment by Nicksonsnowboar on Feb 28, 2022 3:52pm
No Liuna is not a majority holder. Should be concerned about the interest owing , close to loan shark rates because who is going to give them more money. They are not going anywhere fast in a fragile mj market. Best to stay away . If anything miraculous was to happen you have plenty of time to jump in. Buying now you would have a hard time unloading them . Volume is anemic .  Best to buy a ...more  
Comment by shenry24 on Mar 01, 2022 10:39am
I'm still having trouble understanding HOW they are going to pay back that 39 million, plus interest, in 10 months, when they haven't MADE $1 in several years. Yes, their revenue is steadily increasing, but so are their expenses.   In the world I live in, when a "business" keeps operating at a "loss", it's called a hobby.
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities
USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse